JPRN-jRCT2051200158已完成2 期
ROH-201 ophthalmic solution Phase 2a clinical trial
Kitano Takashi0 个研究点目标入组 80 人开始时间: 2021年3月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Tear film break-up time of <= 5 seconds
- •- Have a subjective symptoms of Dry Eye Disease
- •- 20 years and older at the time of Informed Consent
排除标准
- •- Contact lens wearers who cannot discontinue the wear over the trial period
研究者
相似试验
进行中（未招募）
2 期
ROH-201 ophthalmic solution phase IIb clinical trialDry eye diseaseJPRN-jRCT2031220368Mantani Tomomi300
已完成
3 期
Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired BlepharoptosisAcquired BlepharoptosisNCT02436759RVL Pharmaceuticals, Inc.140
已完成
3 期
Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry EyeDry EyeNCT01657253Laboratorios Sophia S.A de C.V.183
已完成
2 期
Efficacy and Safety of PRO-155 Versus Nevanac in Post PhacoemulsificationPhacoemulsification Cataract SurgeryCataractNCT01657266Laboratorios Sophia S.A de C.V.160
已完成
2 期
Nesvategrast (OTT166) in Diabetic Retinopathy (DR)Diabetic RetinopathyNCT05409235OcuTerra Therapeutics, Inc.225